Page last updated: 2024-11-06

metachloridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Metachloridine is a synthetic adrenergic agonist. It is an analog of clonidine, and is similar in structure to other imidazoline-related drugs, such as moxonidine. Metachloridine acts as an α2-adrenergic receptor agonist, and is used in research to study the role of α2-adrenergic receptors in various physiological processes, including blood pressure regulation, sympathetic nervous system function, and pain modulation. Metachloridine is also being investigated for potential therapeutic applications in conditions such as hypertension, anxiety, and depression. It is important to note that metachloridine is not currently approved for clinical use.'

metachloridine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68427
SCHEMBL ID11135360
MeSH IDM0056499

Synonyms (31)

Synonym
2-(m-aminobenzenesulfonamido)-5-chloropyrimidine
wr 6010
n1-(5-chloro-2-pyrimidyl)metanilamide
n'-(5-chloro-2-pyrimidyl) metanilamide
sn 11,437
benzenesulfonamide, 3-amino-n-(5-chloro-2-pyrimidinyl)-
2-metanilamido-5-chloropyrimidine
metanilamide, n'-(5-chloro-2-pyrimidyl)-
metachloridin
nsc-34646
565-36-6
metanilamide, n1-(5-chloro-2-pyrimidinyl)-
wln: t6n cnj bmswr cz& eg
nsc34646
metachloridine
einecs 209-277-4
ai3-17253
3-amino-n-5-chloropyrimidin-2-ylbenzenesulphonamide
brn 0261399
nsc 34646
nsc326060
82204-92-0
metanilamide, n^1-(5-chloro-2-pyrimidinyl)-
3-amino-n-(5-chloropyrimidin-2-yl)benzenesulfonamide
n'-(5-chloro-2-pyrimidyl)metanilamide
4-25-00-02121 (beilstein handbook reference)
nsc 326060
SCHEMBL11135360
DTXSID00873650
B9C4LPT2KP
3-amino-n-(5-chloro-2-pyrimidinyl)benzenesulfonamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (91.67)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.43 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]